# AstraZeneca's COPD Drug Trial Includes Smokers - Date: 2026-03-27 - Category: Biotech & Life Sciences The British-Swedish drugmaker AstraZeneca published positive Phase 3 results Friday for tozorakimab, an anti-IL-33 antibody, in chronic obstructive pulmonary disease — and the interesting part is not the win. ---